Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Clinical trial NCT07578025 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07578025
Sponsor: City of Hope Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v8

Start date: 2026-11-28
Primary completion: 2028-06-24
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.